Murillo-Zamora, E.; Trujillo, X.; Huerta, M.; Riós-Silva, M.; Mendoza-Cano, O.
Effectiveness of BNT162b2 COVID-19 Vaccine in Preventing Severe Symptomatic Infection among Healthcare Workers. Medicina 2021, 57, 746.
https://doi.org/10.3390/medicina57080746
AMA Style
Murillo-Zamora E, Trujillo X, Huerta M, Riós-Silva M, Mendoza-Cano O.
Effectiveness of BNT162b2 COVID-19 Vaccine in Preventing Severe Symptomatic Infection among Healthcare Workers. Medicina. 2021; 57(8):746.
https://doi.org/10.3390/medicina57080746
Chicago/Turabian Style
Murillo-Zamora, Efrén, Xóchitl Trujillo, Miguel Huerta, Mónica Riós-Silva, and Oliver Mendoza-Cano.
2021. "Effectiveness of BNT162b2 COVID-19 Vaccine in Preventing Severe Symptomatic Infection among Healthcare Workers" Medicina 57, no. 8: 746.
https://doi.org/10.3390/medicina57080746
APA Style
Murillo-Zamora, E., Trujillo, X., Huerta, M., Riós-Silva, M., & Mendoza-Cano, O.
(2021). Effectiveness of BNT162b2 COVID-19 Vaccine in Preventing Severe Symptomatic Infection among Healthcare Workers. Medicina, 57(8), 746.
https://doi.org/10.3390/medicina57080746